Jeffrey W. Jacobs - Aug 3, 2021 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Scientific Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Jeffrey W. Jacobs
Stock symbol
ARDX
Transactions as of
Aug 3, 2021
Transactions value $
-$3,805
Form type
4
Date filed
8/5/2021, 05:00 PM
Previous filing
Jun 17, 2021
Next filing
Aug 24, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Options Exercise $5.4K +10K +8.06% $0.54* 134K Aug 3, 2021 Direct
transaction ARDX Common Stock Tax liability -$9.21K -5.61K -4.19% $1.64 128K Aug 3, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDX Stock Option (Right to Buy) Options Exercise $0 -10K -100% $0.00* 0 Aug 3, 2021 Common Stock 10K $0.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were granted in August 2011 and set to expire on August 11, 2021.
F2 Fully exercisable.